Mark Bensink

1.5k total citations
79 papers, 1.1k citations indexed

About

Mark Bensink is a scholar working on Oncology, Nephrology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Bensink has authored 79 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Nephrology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Bensink's work include Neutropenia and Cancer Infections (19 papers), Renal Diseases and Glomerulopathies (13 papers) and Migraine and Headache Studies (11 papers). Mark Bensink is often cited by papers focused on Neutropenia and Cancer Infections (19 papers), Renal Diseases and Glomerulopathies (13 papers) and Migraine and Headache Studies (11 papers). Mark Bensink collaborates with scholars based in United States, Australia and United Kingdom. Mark Bensink's co-authors include Nigel R Armfield, Anthony C Smith, Richard Wootton, Scott D. Ramsey, David Hailey, David Mummy, David Chandler, Bernardo H. L. Goulart, Scott D. Ramsey and Paul Scuffham and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Bensink

71 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Bensink United States 19 339 269 235 166 136 79 1.1k
Roxanne Cosby Canada 17 205 0.6× 334 1.2× 268 1.1× 269 1.6× 98 0.7× 32 1.3k
Colleen Webber Canada 13 184 0.5× 200 0.7× 184 0.8× 87 0.5× 52 0.4× 88 769
Susan Catt United Kingdom 15 631 1.9× 606 2.3× 491 2.1× 250 1.5× 260 1.9× 29 1.6k
Andrew Courtwright United States 23 305 0.9× 133 0.5× 315 1.3× 283 1.7× 152 1.1× 104 1.7k
Rachel Court United Kingdom 21 265 0.8× 172 0.6× 151 0.6× 131 0.8× 35 0.3× 66 1.8k
Simon Fletcher United Kingdom 22 610 1.8× 85 0.3× 790 3.4× 135 0.8× 79 0.6× 57 1.9k
Joseph D Tariman United States 21 443 1.3× 528 2.0× 579 2.5× 75 0.5× 176 1.3× 81 1.6k
C. Langridge United Kingdom 18 437 1.3× 535 2.0× 392 1.7× 128 0.8× 165 1.2× 29 1.5k
Ai Tomotaki Japan 15 204 0.6× 328 1.2× 191 0.8× 237 1.4× 59 0.4× 34 1.2k
Evelyn Chan United States 15 208 0.6× 352 1.3× 472 2.0× 151 0.9× 108 0.8× 27 1.0k

Countries citing papers authored by Mark Bensink

Since Specialization
Citations

This map shows the geographic impact of Mark Bensink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bensink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bensink more than expected).

Fields of papers citing papers by Mark Bensink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bensink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bensink. The network helps show where Mark Bensink may publish in the future.

Co-authorship network of co-authors of Mark Bensink

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bensink. A scholar is included among the top collaborators of Mark Bensink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bensink. Mark Bensink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tuttle, Katherine R., Cami R. Jones, Kenn B. Daratha, et al.. (2025). Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry. Kidney Medicine. 7(4). 100981–100981. 1 indexed citations
2.
Lerma, Edgar V., Kamlesh M. Thakker, Mark Bensink, et al.. (2024). Kidney Failure Events, Cardiovascular Disease Events, and All-Cause Mortality in Patients with IgA Nephropathy in a Real-World Database. Kidney360. 5(3). 427–436. 1 indexed citations
3.
4.
5.
6.
7.
Gibbs, Sarah N., Chinmay Deshpande, Mark Bensink, et al.. (2020). United States Patients’ Perspective of Living With Migraine: Country‐Specific Results From the Global “My Migraine Voice” Survey. Headache The Journal of Head and Face Pain. 60(7). 1351–1364. 25 indexed citations
8.
9.
Weycker, Derek, Hongsheng Wu, Anjali Sharma, et al.. (2019). Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. Journal of Medical Economics. 23(2). 184–192. 30 indexed citations
10.
Weycker, Derek, Charles Bowers, Rajesh Belani, et al.. (2019). Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study. BMC Cancer. 19(1). 792–792. 14 indexed citations
11.
Yücel, Aylin, et al.. (2019). PCN265 BREAST CANCER PATIENT PREFERENCE AND WILLINGNESS TO PAY FOR GRANULOCYTE COLONY-STIMULATING FACTORS (G-CSF). Value in Health. 22. S107–S107. 1 indexed citations
12.
13.
Jakicic, John M., Harold C. Sox, Steven N. Blair, et al.. (2014). Comparative Effectiveness Research. Medicine & Science in Sports & Exercise. 47(8). 1747–1754. 6 indexed citations
14.
Armfield, Nigel R, M G Coulthard, Anthony Slater, et al.. (2014). The effectiveness of telemedicine for paediatric retrieval consultations: rationale and study design for a pragmatic multicentre randomised controlled trial. BMC Health Services Research. 14(1). 546–546. 9 indexed citations
15.
Barocas, Daniel A., et al.. (2014). ECONOMIC EVALUATION OF DIAGNOSTIC LOCALIZATION FOLLOWING BIOCHEMICAL PROSTATE CANCER RECURRENCE. International Journal of Technology Assessment in Health Care. 30(4). 345–353. 3 indexed citations
16.
Bensink, Mark, Scott D. Ramsey, Tracy A. Battaglia, et al.. (2013). Costs and outcomes evaluation of patient navigation after abnormal cancer screening: Evidence from the Patient Navigation Research Program. Cancer. 120(4). 570–578. 42 indexed citations
17.
Bradford, Natalie, Mark Bensink, Helen Irving, et al.. (2012). Paediatric palliative care services in Queensland: an exploration of the barriers, gaps and plans for service development. QUT ePrints (Queensland University of Technology). 15(1). 2–7. 11 indexed citations
18.
Curtis, J. Randall, Ruth A. Engelberg, Mark Bensink, & Scott D. Ramsey. (2012). End-of-Life Care in the Intensive Care Unit: Can We Simultaneously Increase Quality and Reduce Costs?. American Journal of Respiratory and Critical Care Medicine. 186(7). 587–592. 72 indexed citations
19.
Goulart, Bernardo H. L., Mark Bensink, David Mummy, & Scott D. Ramsey. (2012). Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness. Journal of the National Comprehensive Cancer Network. 10(2). 267–275. 92 indexed citations
20.
Bensink, Mark, David Hailey, & Richard Wootton. (2006). The evidence base for home telehealth. Journal of Clinical Psychology. 5(2). 53–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roxanne Cosby Breakdown of academic impact, for papers by Colleen Webber Breakdown of academic impact, for papers by Susan Catt Breakdown of academic impact, for papers by Andrew Courtwright Breakdown of academic impact, for papers by Rachel Court Breakdown of academic impact, for papers by Simon Fletcher Breakdown of academic impact, for papers by Joseph D Tariman Breakdown of academic impact, for papers by C. Langridge Breakdown of academic impact, for papers by Ai Tomotaki Breakdown of academic impact, for papers by Evelyn Chan
Rankless by CCL
2026